The Stimulant Treatment Program: A stepped care approach' - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

The Stimulant Treatment Program: A stepped care approach'

Description:

Rebecca McKetin, Amanda Baker. New South Wales Health STP Steering Committee. Joe Barry, Robert Batey, Rafe Champion, Kanan Gandecha, Chris Shipway ... – PowerPoint PPT presentation

Number of Views:71
Avg rating:3.0/5.0
Slides: 27
Provided by: jamesan4
Category:

less

Transcript and Presenter's Notes

Title: The Stimulant Treatment Program: A stepped care approach'


1
The Stimulant Treatment ProgramA stepped- care
approach.
2
STP Background
  • In 2006, the NSW Government committed 2.45
    million over four years as part of the Co-
    Morbidity Package (COMP) to establish and develop
    Stimulant Treatment Programs.
  • The pilot involves 2 services, located at St.
    Vincents Hospital in Darlinghurst Sydney and the
    other in Newcastle as part of Hunter New England
    Area Health Service
  • This newly established program is the first
    integrated and collaborative treatment program to
    deal systematically with stimulant related
    problems.
  • The project is evaluated independently.

3
Aims of the STP
  • Increase access to treatment for (heavy)
    stimulant users
  • Reduce health, social and legal problems
    associated with stimulant use
  • Assist people using stimulants who want to reduce
    or cease use
  • Support people who are abstinent from relapsing
    to problematic stimulant use

4
Aims of the STP
  • Provide a combination of brief interventions,
    individual counselling programs and education for
    parents and significant others
  • Provide substitution pharmacotherapy treatment
    for severely dependent stimulant users
    currently only conducted at St Vincents STP.

5
Key tasks of the STP
  • Promote services that are attractive to stimulant
    users,
  • Retain them long enough to achieve lasting
    change and
  • To creatively engineer access points which
    proactively engage potential clients in
    partnership with other local service providers

6
Engaging stimulant users
  • UK evidence suggests that targeted programs for
    users of stimulant drugs are effective
  • Stimulant users report seeking services that are
    specialised, separate and distinct from
    hospital/health campuses
  • Stimulant users that we see report that there had
    been an unmet need in the form of a specific
    stimulant service
  • It was important for us to also foster links with
    other support services and user organisations,
    already supporting those with stimulant issues

7
Components of effective treatment
  • Competent staff and service
  • Immediate access
  • Rapid response
  • Client-counselor relationship
  • Effective referral and induction processes
  • Flexibility and a tailored response to the
    individual

8
Stepped care approach
  • According to Sobell Sobell (1999), a stepped
    care approach involves three fundamental
    principles of health care
  • Treatment should be individualized
  • The treatments selected should be consistent with
    the contemporary research literature.
  • Clinical judgment by experienced clinicians
    lacks strong empirical validation but is critical
    for determining when to choose particular
    treatment options.
  • The treatment should be least restrictive but
    still likely to work.

9
Process of treatment at the STP
  • Triage and referral
  • Intake
  • Assessment
  • Treatment offered
  • Counselling interventions
  • Counselling plus pharmacotherapy

10
Triage and Referral
  • Stimulant users often seek help in a crisis.
  • Easy and immediate access to support, advice and
    referral via 24-hour telephone helplines are
    recommended by users and have been found to be
    effective in practice. This service is provided
    through the STP helpline, available 24/7
  • Preliminary findings from the evaluation report,
    indicates the majority of new clients
    self-referred.

11
Intake
  • After contact is made, a rapid response is widely
    thought to be the key to engaging stimulant users
    in treatment.
  • Treatment service is open weekdays from 8.30am to
    5pm.
  • Intake asks about
  • what the person has been using
  • the impact stimulants have had on their life
  • what support the person seeks
  • Brief intervention is offered

12
Assessment
  • Aims to gain a broad picture of the ways
    stimulants have affected the persons life
    including health, welfare and relationships.
  • Initial assessment is protracted due to
    suspiciousness and paranoia.
  • Engagement and developing the therapeutic
    alliance early in treatment is therefore critical.

13
STP Counselling
  • Is the core work undertaken with all people
    admitted
  • Stepped care approach is applied, with increasing
    intensity of treatment depending on the persons
    needs.
  • Support is provided primarily through individual
    sessions while involvement group work is also
    encouraged.
  • Motivational interviewing and a CBT approach is
    taken by half the counselling team following the
    work of Baker, Lee et.al. (2005). The other half
    of the team use Narrative therapy.
  • Assertive follow-up is standard practice across
    the teams

14
Dexamphetamine Pharmacotherapy
  • Patients who continue to experience serious and
    multiple harms associated with their stimulant
    use despite active involvement in counselling may
    be referred for assessment for pharmacological
    treatment.
  • There are very strict entry criteria for
    pharmacotherapy treatment
  • Pharmacotherapy is best implemented on a
    case-by-case basis rather than as routine
    treatments.

15
Eligibility criteria
  • Over 21 years of age.
  • SDS score greater than 4, indicating severe
    amphetamine dependence
  • Currently experiencing major adverse consequences
    from use impacting on physical health and/ or
    mental health
  • History of problematic stimulant abuse for at
    least 2 years
  • History of at least 2 previous episodes of
    substance use treatment for amphetamine
    dependence
  • Stable accommodation within the local
    geographical area (such that daily attendance for
    dosing is feasible)
  • Opinion by a doctor who is independent of the STP
    indicting that dexamphetamine substitution is
    warranted

16
Exclusion criteria
  • A currently active psychosis or recent (within
    the last 6 months) confirmed diagnosis of
    schizophrenia, schizoaffective disorder, bi-polar
    disorder, or Tourettes syndrome.
  • A major medical contraindication
  • Substance dependence diagnosis of the following
    substances opioids, benzodiazepines,
    barbiturates, alcohol.
  • Concurrent methadone or buprenorphine
    substitution maintenance treatment
  • Use within the last month of mono-amine oxidize
    inhibitors (MAOIs).

17
Preliminary Evaluation
  • Preliminary 6 month evaluation 2006-2007
  • Promote services that attractive to stimulant
    users
  • Retain people long enough to effect change
  • To creatively engineer access points to
    proactively engage potential clients

18
Evaluation Promote services that are attractive
to stimulant users
  • The STPs were effective in their capacity to
    attract primary methamphetamine users into
    treatment, with 49 (n115) of service users
    report being treatment naive.
  • At St Vincents Hospital
  • 104 patients have presented to the SVH STP with
    all patients receiving brief interventions.
  • 63 of these people referred on to more in depth
    counseling interventions.
  • 3 patients received pharmacological treatment of
    dexamphetamine.
  • In the Hunter,
  • 112 people presented to treatment, with 52 going
    on to assessment phase and 35 into treatment.
  • Total of 216 people accessed the 2 services in
    the 7 months to June 07.

19
Evaluation Retain people long enough to achieve
change
  • Dependence
  • Higher levels of dependence occur by the use of
    higher concentration forms of methamphetamine
    such as crystal and base with more efficient
    means of use such as smoking and injecting.
  • Overall 66 inject while 27 smoke.
  • All patients of the STP were stimulant dependent
    as measured by the SDS.
  • At 3 month follow up, only a third remained
    dependent on stimulants.
  • Physical health
  • SF12 at baseline 84 of patients reported poor
    health
  • At follow up 8 of patients scored in the same
    range

20
Evaluation Retain people long enough to achieve
change
  • Mental health
  • History of mental illness
  • 21 nil, 25 1 diagnosis, 31 2 diagnoses,
    15 3 diagnoses.
  • Reported diagnoses include
  • 35 drug induced psychosis, 70 depression,
    39 anxiety.
  • K10 at baseline, 75 of patients were severely
    distressed
  • At 3 month follow up, 8 of patients were
    severely distressed.
  • On the Brief Psychiatric Rating Scale
  • 83 rated on hostility, 83 suspiciousness,
    58 hallucinations, 38 reported unusual thoughts.

21
Evaluation To creatively engineer access points
to proactively

engage potential clients
  • Patients seen on the hospital wards, the PECC
    unit, Emergency Department or Psychiatric
    Hospital all receive brief interventions
  • Increased awareness of service availability
  • Referral by key agencies
  • Effective referral and induction processes can
    help clients feel more motivated to enter
    treatment.
  • Referral and coordinated care plans developed
    with patients and key agencies is often necessary
    and best practice
  • Word of mouth from service users has been
    critical
  • STP has demonstrated its acceptability to the
    target population.

22
Implications for service delivery
  • High levels of paranoia and suspiciousness can
    provide a significant barrier to treatment entry.
  • Engagement and developing the therapeutic
    alliance early in treatment is therefore
    critical.
  • Routine screening is crucial including assessment
    of psychotic symptoms and suicidal thoughts.
  • Almost half of clients had no previous treatment.
  • Therefore, identifying their hopes and
    expectations of service is critical.
  • Primary reason for presenting
  • Hopes for change
  • How we can support this change
  • Important to develop creative ways of working.

23
Challenges
  • Infrastructure costs setting up within a non area
    health service environment
  • Relocation of Newcastle clinic
  • Communication between sites
  • Models of service delivery
  • Follow-up rates for evaluation
  • Initial client expectations around
    pharmacotherapy

24
Case Studies
  • Rick 20 year old male who had only recently
    moved from the country to Sydney to be amongst
    the gay party scene, started smoking, then
    injecting ice, cocaine and using GHB.
  • Became every weekend and then into the week, used
    GHB in a suicide attempt and was referred via the
    PECC unit
  • Meth use a strong feature of his sexual practice,
    recent HIV diagnosis
  • Marie 28 year old female smoking ice since
    2005, became problematic a year later smoking
    around 3 ½ grams per week from the moment she
    woke and throughout her working day.
  • Prescribed Zoloft for depression, reported
    frequent suicidal thoughts
  • Used ice to maintain weight, significant issues
    around body image
  • Felix 30 year old migrant with history of
    trauma and suicide. Injecting ice (2-3) points a
    day, homeless and HIV positive.
  • Case managed by a number of community-based
    support services, therefore a coordinated
    approach was needed with regular case
    conferencing to address basic needs such as
    housing etc

25
Future Plans
  • Promotion initially (2006-07) information was
    sent to health service providers in the local
    areas of both services. Further promotion is
    planned with the release of the first evaluation
    report.
  • Further evaluation
  • Dexamphetamine options and trials
  • Alternative therapies
  • Community partnerships

26
Acknowledgments
  • Clients involved in the service who gave of their
    time for the evaluation
  • St Vincents Hospital
  • Alex Wodak, Tarra Adam, Rosara Squirchuk, Jim
    Villamor, Donna Brady, Bronwyn Crosby, Carol
    Stubley, Sue Ivanyi, Samantha Forbes, Jeanette
    Wong.
  • Hunter New England Area Health Service
  • Adrian Dunlop, Bill Robertson, Julie Humphreys,
    Raka Tierney, Bruce Tulloch, Liz Knock.
  • National Drug and Alcohol Research Centre
  • Rebecca McKetin, Amanda Baker
  • New South Wales Health STP Steering Committee
  • Joe Barry, Robert Batey, Rafe Champion, Kanan
    Gandecha, Chris Shipway
Write a Comment
User Comments (0)
About PowerShow.com